| Blood-based protein biomarkers for diagnosis of Alzheimer disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of neurology 69 (10), 1318-1325, 2012 | 485 | 2012 |
| Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription SM Laws, E Hone, S Gandy, RN Martins Journal of neurochemistry 84 (6), 1215-1236, 2003 | 317 | 2003 |
| The role of beta amyloid in Alzheimer’s disease: still a cause of everything or the only one who got caught? G Verdile, S Fuller, CS Atwood, SM Laws, SE Gandy, RN Martins Pharmacological Research 50 (4), 397-409, 2004 | 280 | 2004 |
| Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ... Molecular psychiatry 18 (8), 875-881, 2013 | 274 | 2013 |
| Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a … SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ... The Lancet Neurology 15 (10), 1044-1053, 2016 | 233 | 2016 |
| Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging VB Gupta, SM Laws, VL Villemagne, D Ames, AI Bush, KA Ellis, JK Lui, ... Neurology 76 (12), 1091-1098, 2011 | 195 | 2011 |
| The relationship between sleep quality and brain amyloid burden BM Brown, SR Rainey-Smith, VL Villemagne, M Weinborn, RS Bucks, ... Sleep 39 (5), 1063-1068, 2016 | 177 | 2016 |
| Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study KE Pike, KA Ellis, VL Villemagne, N Good, G Chételat, D Ames, C Szoeke, ... Neuropsychologia 49 (9), 2384-2390, 2011 | 172 | 2011 |
| Examination of the current top candidate genes for AD in a genome-wide association study TM Feulner, SM Laws, P Friedrich, S Wagenpfeil, SHR Wurst, C Riehle, ... Molecular psychiatry 15 (7), 756-766, 2010 | 171 | 2010 |
| Plasma amyloid-β as a biomarker in Alzheimer's disease: the AIBL study of aging JK Lui, SM Laws, QX Li, VL Villemagne, D Ames, B Brown, AI Bush, ... Journal of Alzheimer's disease 20 (4), 1233-1242, 2010 | 168 | 2010 |
| Aβ-amyloid and tau imaging in dementia VL Villemagne, V Dore, P Bourgeat, SC Burnham, S Laws, O Salvado, ... Seminars in nuclear medicine 47 (1), 75-88, 2017 | 162 | 2017 |
| Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease A Rembach, NG Faux, AD Watt, KK Pertile, RL Rumble, BO Trounson, ... Alzheimer's & Dementia 10 (1), 53-61, 2014 | 160 | 2014 |
| Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture Q Zhang, J Sidorenko, B Couvy-Duchesne, RE Marioni, MJ Wright, ... Nature communications 11 (1), 4799, 2020 | 159 | 2020 |
| BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease YY Lim, VL Villemagne, SM Laws, D Ames, RH Pietrzak, KA Ellis, ... Neurobiology of aging 34 (11), 2457-2464, 2013 | 150 | 2013 |
| APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease YY Lim, VL Villemagne, SM Laws, RH Pietrzak, PJ Snyder, D Ames, ... Molecular psychiatry 20 (11), 1322-1328, 2015 | 146 | 2015 |
| Olfactory discrimination predicts cognitive decline among community-dwelling older adults HR Sohrabi, KA Bates, MG Weinborn, ANB Johnston, A Bahramian, ... Translational psychiatry 2 (5), e118-e118, 2012 | 142 | 2012 |
| Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ... Journal of Alzheimer's Disease 62 (3), 965-992, 2018 | 141 | 2018 |
| Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease G Verdile, SM Laws, D Henley, D Ames, AI Bush, KA Ellis, NG Faux, ... Molecular psychiatry 19 (1), 69-75, 2014 | 137 | 2014 |
| Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden SR Rainey-Smith, GN Mazzucchelli, VL Villemagne, BM Brown, T Porter, ... Translational psychiatry 8 (1), 47, 2018 | 134 | 2018 |
| A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ... Molecular psychiatry 19 (4), 519-526, 2014 | 134 | 2014 |
Colin Louis MastersThe University of MelbourneVerified email at florey.edu.au
